Clifford Chance (Washington D.C.)

Leigh L. Oliver

Clifford Chance (Washington D.C.)
Partner

Leigh Oliver specializes in antitrust issues ranging from bet-the-company merger control matters to state and federal antitrust investigations. She has two decades of experience advising clients in heavily scrutinized industries, including healthcare, life sciences, aerospace and defense and industrials. She regularly represents clients before federal and state antitrust agencies and in merger litigation in federal court.

Distinctions

Linked authors

Clifford Chance (Warsaw)
Clifford Chance (Brussels)
Clifford Chance (Washington D.C.)
Clifford Chance (Milano)
Clifford Chance (Sydney)

Articles

1119 Bulletin

Bob Leibenluft, Leigh L. Oliver, Jonathan Elsasser The US FTC initiates proceedings against two hospitals to prevent their proposed merger (Hackensack Meridian Health / Englewood Healthcare)

134

On 4 August 2021, the District Court of New Jersey granted the Federal Trade Commission’s (FTC) motion for preliminary injunction, preventing Hackensack Meridian Health (HMH) and Englewood Healthcare (Englewood) from closing their proposed merger pending an administrative trial before an FTC (...)

Arjun Garg, David Horowitz, Kevin Sheys, Chuck Loughlin, Edith Ramirez, Logan M. Breed, Leigh L. Oliver The US President Joe Biden issues sweeping executive order targeting corporate consolidation and anticompetitive activity in the labor, financial services, health care, transportation, telecommunications, agricultural, and tech markets

654

On 9 July 2021 President Biden signed a far-reaching executive order intended to promote competition in the American economy. The order targets perceived corporate consolidation and anticompetitive activity in the labor, financial services, health care, transportation, telecommunications, (...)

Send a message